nodes	percent_of_prediction	percent_of_DWPC	metapath
Alogliptin—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0664	0.0809	CbGbCtD
Alogliptin—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0625	0.0761	CbGbCtD
Alogliptin—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0625	0.0761	CbGbCtD
Alogliptin—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.0565	0.0688	CbGbCtD
Alogliptin—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.0565	0.0688	CbGbCtD
Alogliptin—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.0488	0.0594	CbGbCtD
Alogliptin—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.0473	0.0576	CbGbCtD
Alogliptin—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.0428	0.0521	CbGbCtD
Alogliptin—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.0428	0.0521	CbGbCtD
Alogliptin—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0422	0.0514	CbGbCtD
Alogliptin—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0397	0.0484	CbGbCtD
Alogliptin—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0397	0.0484	CbGbCtD
Alogliptin—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0359	0.0437	CbGbCtD
Alogliptin—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0359	0.0437	CbGbCtD
Alogliptin—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.031	0.0378	CbGbCtD
Alogliptin—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0301	0.0366	CbGbCtD
Alogliptin—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.0272	0.0331	CbGbCtD
Alogliptin—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.0272	0.0331	CbGbCtD
Alogliptin—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0261	0.0318	CbGbCtD
Alogliptin—DPP4—blood plasma—acquired immunodeficiency syndrome	0.0046	0.173	CbGeAlD
Alogliptin—Diabetes mellitus—Amprenavir—acquired immunodeficiency syndrome	0.00368	0.0242	CcSEcCtD
Alogliptin—Diabetes mellitus—Didanosine—acquired immunodeficiency syndrome	0.00336	0.0221	CcSEcCtD
Alogliptin—Hypoglycaemia—Didanosine—acquired immunodeficiency syndrome	0.00299	0.0197	CcSEcCtD
Alogliptin—Diabetes mellitus—Nelfinavir—acquired immunodeficiency syndrome	0.00292	0.0192	CcSEcCtD
Alogliptin—Diabetes mellitus—Stavudine—acquired immunodeficiency syndrome	0.00291	0.0192	CcSEcCtD
Alogliptin—Hypoglycaemia—Nelfinavir—acquired immunodeficiency syndrome	0.00261	0.0171	CcSEcCtD
Alogliptin—Pancreatitis—Didanosine—acquired immunodeficiency syndrome	0.00247	0.0163	CcSEcCtD
Alogliptin—Stevens-Johnson syndrome—Amprenavir—acquired immunodeficiency syndrome	0.00245	0.0161	CcSEcCtD
Alogliptin—Diabetes mellitus—Indinavir—acquired immunodeficiency syndrome	0.00236	0.0155	CcSEcCtD
Alogliptin—Pancreatitis—Nevirapine—acquired immunodeficiency syndrome	0.00222	0.0146	CcSEcCtD
Alogliptin—Pancreatitis—Nelfinavir—acquired immunodeficiency syndrome	0.00215	0.0142	CcSEcCtD
Alogliptin—Pancreatitis—Stavudine—acquired immunodeficiency syndrome	0.00215	0.0141	CcSEcCtD
Alogliptin—Pancreatitis—Abacavir—acquired immunodeficiency syndrome	0.00212	0.0139	CcSEcCtD
Alogliptin—Erythema multiforme—Amprenavir—acquired immunodeficiency syndrome	0.0021	0.0138	CcSEcCtD
Alogliptin—Stevens-Johnson syndrome—Nevirapine—acquired immunodeficiency syndrome	0.00201	0.0132	CcSEcCtD
Alogliptin—Nasopharyngitis—Zidovudine—acquired immunodeficiency syndrome	0.00197	0.013	CcSEcCtD
Alogliptin—Diabetes mellitus—Ritonavir—acquired immunodeficiency syndrome	0.00197	0.013	CcSEcCtD
Alogliptin—Stevens-Johnson syndrome—Abacavir—acquired immunodeficiency syndrome	0.00191	0.0126	CcSEcCtD
Alogliptin—Diabetes mellitus—Saquinavir—acquired immunodeficiency syndrome	0.0019	0.0125	CcSEcCtD
Alogliptin—Pancreatitis—Zidovudine—acquired immunodeficiency syndrome	0.00187	0.0123	CcSEcCtD
Alogliptin—DPP4—lymphoid tissue—acquired immunodeficiency syndrome	0.00179	0.0675	CbGeAlD
Alogliptin—DPP4—digestive system—acquired immunodeficiency syndrome	0.00177	0.0667	CbGeAlD
Alogliptin—Angioedema—Amprenavir—acquired immunodeficiency syndrome	0.00176	0.0116	CcSEcCtD
Alogliptin—Pancreatitis—Indinavir—acquired immunodeficiency syndrome	0.00174	0.0114	CcSEcCtD
Alogliptin—Nasopharyngitis—Efavirenz—acquired immunodeficiency syndrome	0.00173	0.0114	CcSEcCtD
Alogliptin—Erythema multiforme—Nevirapine—acquired immunodeficiency syndrome	0.00172	0.0113	CcSEcCtD
Alogliptin—Hypoglycaemia—Saquinavir—acquired immunodeficiency syndrome	0.00169	0.0111	CcSEcCtD
Alogliptin—DPP4—blood—acquired immunodeficiency syndrome	0.00169	0.0635	CbGeAlD
Alogliptin—Stevens-Johnson syndrome—Zidovudine—acquired immunodeficiency syndrome	0.00168	0.0111	CcSEcCtD
Alogliptin—Erythema multiforme—Nelfinavir—acquired immunodeficiency syndrome	0.00166	0.0109	CcSEcCtD
Alogliptin—Upper respiratory tract infection—Indinavir—acquired immunodeficiency syndrome	0.00165	0.0108	CcSEcCtD
Alogliptin—Pancreatitis—Efavirenz—acquired immunodeficiency syndrome	0.00164	0.0108	CcSEcCtD
Alogliptin—Erythema multiforme—Abacavir—acquired immunodeficiency syndrome	0.00163	0.0107	CcSEcCtD
Alogliptin—DPP4—bone marrow—acquired immunodeficiency syndrome	0.00163	0.0614	CbGeAlD
Alogliptin—Hypoglycaemia—Lamivudine—acquired immunodeficiency syndrome	0.00161	0.0106	CcSEcCtD
Alogliptin—Pancreatitis—Delavirdine—acquired immunodeficiency syndrome	0.00157	0.0103	CcSEcCtD
Alogliptin—Stevens-Johnson syndrome—Indinavir—acquired immunodeficiency syndrome	0.00157	0.0103	CcSEcCtD
Alogliptin—DPP4—vagina—acquired immunodeficiency syndrome	0.00156	0.0589	CbGeAlD
Alogliptin—Upper respiratory tract infection—Efavirenz—acquired immunodeficiency syndrome	0.00156	0.0102	CcSEcCtD
Alogliptin—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.0015	0.0565	CbGeAlD
Alogliptin—Upper respiratory tract infection—Delavirdine—acquired immunodeficiency syndrome	0.00149	0.00979	CcSEcCtD
Alogliptin—Stevens-Johnson syndrome—Efavirenz—acquired immunodeficiency syndrome	0.00148	0.00973	CcSEcCtD
Alogliptin—DPP4—lung—acquired immunodeficiency syndrome	0.00148	0.0557	CbGeAlD
Alogliptin—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.00148	0.0556	CbGeAlD
Alogliptin—Pancreatitis—Ritonavir—acquired immunodeficiency syndrome	0.00145	0.00955	CcSEcCtD
Alogliptin—Angioedema—Nevirapine—acquired immunodeficiency syndrome	0.00144	0.0095	CcSEcCtD
Alogliptin—Erythema multiforme—Zidovudine—acquired immunodeficiency syndrome	0.00144	0.00948	CcSEcCtD
Alogliptin—Anaphylactic shock—Didanosine—acquired immunodeficiency syndrome	0.00144	0.00944	CcSEcCtD
Alogliptin—Stevens-Johnson syndrome—Delavirdine—acquired immunodeficiency syndrome	0.00142	0.00931	CcSEcCtD
Alogliptin—Nasopharyngitis—Lamivudine—acquired immunodeficiency syndrome	0.00141	0.00925	CcSEcCtD
Alogliptin—Pancreatitis—Saquinavir—acquired immunodeficiency syndrome	0.0014	0.00919	CcSEcCtD
Alogliptin—DPP4—nervous system—acquired immunodeficiency syndrome	0.00137	0.0516	CbGeAlD
Alogliptin—Erythema multiforme—Indinavir—acquired immunodeficiency syndrome	0.00134	0.00882	CcSEcCtD
Alogliptin—Pancreatitis—Lamivudine—acquired immunodeficiency syndrome	0.00133	0.00877	CcSEcCtD
Alogliptin—Upper respiratory tract infection—Saquinavir—acquired immunodeficiency syndrome	0.00132	0.00871	CcSEcCtD
Alogliptin—DPP4—central nervous system—acquired immunodeficiency syndrome	0.00132	0.0496	CbGeAlD
Alogliptin—Anaphylactic shock—Nevirapine—acquired immunodeficiency syndrome	0.00129	0.00849	CcSEcCtD
Alogliptin—Erythema multiforme—Efavirenz—acquired immunodeficiency syndrome	0.00127	0.00833	CcSEcCtD
Alogliptin—Stevens-Johnson syndrome—Saquinavir—acquired immunodeficiency syndrome	0.00126	0.00829	CcSEcCtD
Alogliptin—Anaphylactic shock—Abacavir—acquired immunodeficiency syndrome	0.00123	0.00807	CcSEcCtD
Alogliptin—Angioedema—Zidovudine—acquired immunodeficiency syndrome	0.00121	0.00798	CcSEcCtD
Alogliptin—Erythema multiforme—Delavirdine—acquired immunodeficiency syndrome	0.00121	0.00797	CcSEcCtD
Alogliptin—Stevens-Johnson syndrome—Lamivudine—acquired immunodeficiency syndrome	0.0012	0.0079	CcSEcCtD
Alogliptin—Angioedema—Indinavir—acquired immunodeficiency syndrome	0.00113	0.00742	CcSEcCtD
Alogliptin—Erythema multiforme—Ritonavir—acquired immunodeficiency syndrome	0.00112	0.00737	CcSEcCtD
Alogliptin—Anaphylactic shock—Zidovudine—acquired immunodeficiency syndrome	0.00108	0.00712	CcSEcCtD
Alogliptin—Erythema multiforme—Saquinavir—acquired immunodeficiency syndrome	0.00108	0.00709	CcSEcCtD
Alogliptin—Angioedema—Efavirenz—acquired immunodeficiency syndrome	0.00107	0.00701	CcSEcCtD
Alogliptin—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.00106	0.00696	CcSEcCtD
Alogliptin—DPP4—brain—acquired immunodeficiency syndrome	0.00105	0.0394	CbGeAlD
Alogliptin—Erythema multiforme—Lamivudine—acquired immunodeficiency syndrome	0.00103	0.00677	CcSEcCtD
Alogliptin—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.00103	0.00674	CcSEcCtD
Alogliptin—Angioedema—Delavirdine—acquired immunodeficiency syndrome	0.00102	0.00671	CcSEcCtD
Alogliptin—DPP4—lymph node—acquired immunodeficiency syndrome	0.00101	0.0381	CbGeAlD
Alogliptin—Anaphylactic shock—Indinavir—acquired immunodeficiency syndrome	0.00101	0.00662	CcSEcCtD
Alogliptin—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.000993	0.00653	CcSEcCtD
Alogliptin—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000993	0.00653	CcSEcCtD
Alogliptin—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.000992	0.00652	CcSEcCtD
Alogliptin—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.00099	0.00651	CcSEcCtD
Alogliptin—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000986	0.00649	CcSEcCtD
Alogliptin—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.000975	0.00641	CcSEcCtD
Alogliptin—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.000951	0.00625	CcSEcCtD
Alogliptin—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000921	0.00606	CcSEcCtD
Alogliptin—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000918	0.00604	CcSEcCtD
Alogliptin—Rash—Didanosine—acquired immunodeficiency syndrome	0.000905	0.00595	CcSEcCtD
Alogliptin—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000904	0.00595	CcSEcCtD
Alogliptin—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000904	0.00595	CcSEcCtD
Alogliptin—Headache—Didanosine—acquired immunodeficiency syndrome	0.000899	0.00591	CcSEcCtD
Alogliptin—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000866	0.00569	CcSEcCtD
Alogliptin—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.00086	0.00566	CcSEcCtD
Alogliptin—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000814	0.00535	CcSEcCtD
Alogliptin—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000813	0.00535	CcSEcCtD
Alogliptin—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000808	0.00532	CcSEcCtD
Alogliptin—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.0008	0.00526	CcSEcCtD
Alogliptin—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000788	0.00518	CcSEcCtD
Alogliptin—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000787	0.00518	CcSEcCtD
Alogliptin—Rash—Stavudine—acquired immunodeficiency syndrome	0.000786	0.00517	CcSEcCtD
Alogliptin—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000785	0.00516	CcSEcCtD
Alogliptin—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000783	0.00515	CcSEcCtD
Alogliptin—Headache—Stavudine—acquired immunodeficiency syndrome	0.000781	0.00513	CcSEcCtD
Alogliptin—Rash—Abacavir—acquired immunodeficiency syndrome	0.000774	0.00509	CcSEcCtD
Alogliptin—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000773	0.00509	CcSEcCtD
Alogliptin—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000773	0.00509	CcSEcCtD
Alogliptin—Headache—Abacavir—acquired immunodeficiency syndrome	0.000769	0.00506	CcSEcCtD
Alogliptin—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000756	0.00497	CcSEcCtD
Alogliptin—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000742	0.00488	CcSEcCtD
Alogliptin—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000723	0.00476	CcSEcCtD
Alogliptin—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000701	0.00461	CcSEcCtD
Alogliptin—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000683	0.00449	CcSEcCtD
Alogliptin—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000682	0.00449	CcSEcCtD
Alogliptin—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000678	0.00446	CcSEcCtD
Alogliptin—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000671	0.00441	CcSEcCtD
Alogliptin—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000669	0.0044	CcSEcCtD
Alogliptin—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000644	0.00423	CcSEcCtD
Alogliptin—Rash—Indinavir—acquired immunodeficiency syndrome	0.000635	0.00418	CcSEcCtD
Alogliptin—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000634	0.00417	CcSEcCtD
Alogliptin—Headache—Indinavir—acquired immunodeficiency syndrome	0.000631	0.00415	CcSEcCtD
Alogliptin—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.00062	0.00408	CcSEcCtD
Alogliptin—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000614	0.00404	CcSEcCtD
Alogliptin—Rash—Efavirenz—acquired immunodeficiency syndrome	0.0006	0.00395	CcSEcCtD
Alogliptin—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000599	0.00394	CcSEcCtD
Alogliptin—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000597	0.00393	CcSEcCtD
Alogliptin—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000596	0.00392	CcSEcCtD
Alogliptin—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000577	0.0217	CbGeAlD
Alogliptin—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000574	0.00378	CcSEcCtD
Alogliptin—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000574	0.00377	CcSEcCtD
Alogliptin—Headache—Delavirdine—acquired immunodeficiency syndrome	0.00057	0.00375	CcSEcCtD
Alogliptin—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.00057	0.00375	CcSEcCtD
Alogliptin—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000568	0.0214	CbGeAlD
Alogliptin—CYP3A4—blood—acquired immunodeficiency syndrome	0.00055	0.0207	CbGeAlD
Alogliptin—CYP2D6—blood—acquired immunodeficiency syndrome	0.000541	0.0204	CbGeAlD
Alogliptin—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000531	0.00349	CcSEcCtD
Alogliptin—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.00053	0.00349	CcSEcCtD
Alogliptin—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000527	0.00347	CcSEcCtD
Alogliptin—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000511	0.00336	CcSEcCtD
Alogliptin—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.00051	0.00336	CcSEcCtD
Alogliptin—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000508	0.00334	CcSEcCtD
Alogliptin—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000487	0.00321	CcSEcCtD
Alogliptin—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000487	0.0032	CcSEcCtD
Alogliptin—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000484	0.00319	CcSEcCtD
Alogliptin—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000446	0.0168	CbGeAlD
Alogliptin—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000439	0.0165	CbGeAlD
Alogliptin—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.00043	0.0162	CbGeAlD
Alogliptin—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000423	0.0159	CbGeAlD
Alogliptin—CYP2D6—brain—acquired immunodeficiency syndrome	0.000336	0.0126	CbGeAlD
